4-methoxyamphetamine has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YK; Cho, JS; Cho, WK; Hong, YA; Hwang, HS; Kim, SY; Kim, Y; Yang, CW; Yoon, HE | 1 |
| Araki, S; Haneda, M; Hidaka, H; Isono, M; Kikkawa, R; Nakagawa, T; Shikano, T; Sugimoto, T; Togawa, M | 1 |
2 other study(ies) available for 4-methoxyamphetamine and Diabetic Retinopathy
| Article | Year |
|---|---|
Retinopathy and left ventricular hypertrophy in patients with chronic kidney disease: Interrelationship and impact on clinical outcomes.
Topics: Aged; Aged, 80 and over; Death; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertensive Retinopathy; Hypertrophy, Left Ventricular; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Microalbuminuria is not associated with cardiovascular death in Japanese NIDDM.
Topics: Aged; Aged, 80 and over; Albuminuria; Blood Pressure; Cholesterol; Death; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertension; Japan; Male; Middle Aged; Triglycerides | 1997 |